The combination of nirmatrelvir tablets and ritonavir tablets is a product that the FDA is allowing to be given for emergency use to treat COVID-19. It is used by people 12 years of age and older who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized.
Paxista Nirmatrelvir 150mg And Ritonavir 100mg Tablet
$2,500.00
| Manufacture By | 50 mg |
| Prescription/Non prescription | Non prescription |
| Treatment | Covid-19 |
| Composition | Nirmatrelvir 150mg and Ritonavir 100mg |
| Form | Tablet |
| Brand | Paxista |
| Strength | 150mg and 100mg |
| Country of Origin | Made in India |
Minimum order quantity: 10 Box
